Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile

Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
56 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Haemonetics Corporation (Haemonetics) is a healthcare company, which offers blood management technology and software solutions. The companys portfolio consists of integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and bio-pharmaceutical companies through a direct sales force and independent distributors.

Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDME707D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 201652
Haemonetics Corporation, Medical Equipment Deals By Type, 2010 to YTD 201671
Haemonetics Corporation, Medical Equipment, Deals By Region, 2010 to YTD 201681
Haemonetics Corporation, Medical Equipment, Deals By Market, 2010 to YTD 201691
Haemonetics Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016101
Haemonetics Corporation, Medical Equipment, Deal Details119
  Asset Purchase111
    Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million112
  Partnerships131
    HemaCare Enters Into Licensing Agreement With Haemonetics131
    Haemonetics Enters Into Licensing Agreement With Alba Bioscience141
    Cerus Enters into Agreement with Haemonetics151
  Acquisition161
    Haemonetics Completes Acquisition Of Hemerus Medical, Leukoreduction Technologies Provider, For Up To US$41 Million162
    Haemonetics Completes Tender Offer For Acquisition Of Global Med Technologies182
Haemonetics Corporation - Key Competitors201
Key Employees211
Locations And Subsidiaries223
  Head Office221
  Other Locations &Subsidiaries223
Recent Developments251
Financial Announcements251
May 02, 2016: Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported254
Feb 01, 2016: Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported293
Nov 04, 2015: Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance324
Jul 27, 2015: Haemonetics Reports 1St Quarter Fiscal 2016 Revenue Of $213 Million and Adjusted Eps Of $0.35, Reaffirms Full Fiscal Year Guidance364
Apr 27, 2015: Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85;404
Jan 29, 2015: Haemonetics Reports 3rd Quarter Fiscal 2015 Revenue of $232 Million and Adjusted EPS of $0.53; Reaffirms Revenue and EPS Guidance444
Corporate Communications481
Aug 01, 2016: Haemonetics Appoints Bill Burke CFO481
May 09, 2016: Haemonetics Announces Christopher Simon as President and Chief Executive Officer491
Apr 14, 2016: Haemonetics Announces CFO's Retirement501
Sep 29, 2015: Haemonetics Corporation Appoints Ron Gelbman as Interim CEO; CEO Brian Concannon Resigns511
Apr 27, 2015: Haemonetics Expands Executive Management Roles To Complement Global Growth Strategy521
Government and Public Interest531
Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean532
Other Significant Developments551
May 09, 2016: Haemonetics Provides Fiscal 2017 Guidance551
Appendix561
  Methodology561
  About GlobalData561
  Contact Us561
  Disclaimer561

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Haemonetics-Corporation-HAE-Medical-Equipment-Deals-and-Alliances-Profile-2148-9546>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Haemonetics-Corporation-HAE-Medical-Equipment-Deals-and-Alliances-Profile-2148-9546>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research